Human complete NFAT1 deficiency causes a triad of joint contractures, osteochondromas, and B-cell malignancy.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
27 10 2022
Historique:
accepted: 20 06 2022
received: 26 01 2022
pubmed: 6 7 2022
medline: 1 11 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

The discovery of humans with monogenic disorders has a rich history of generating new insights into biology. Here we report the first human identified with complete deficiency of nuclear factor of activated T cells 1 (NFAT1). NFAT1, encoded by NFATC2, mediates calcium-calcineurin signals that drive cell activation, proliferation, and survival. The patient is homozygous for a damaging germline NFATC2 variant (c.2023_2026delTACC; p.Tyr675Thrfs∗18) and presented with joint contractures, osteochondromas, and recurrent B-cell lymphoma. Absence of NFAT1 protein in chondrocytes caused enrichment in prosurvival and inflammatory genes. Systematic single-cell-omic analyses in PBMCs revealed an environment that promotes lymphomagenesis with accumulation of naïve B cells (enriched for oncogenic signatures MYC and JAK1), exhausted CD4+ T cells, impaired T follicular helper cells, and aberrant CD8+ T cells. This work highlights the pleiotropic role of human NFAT1, will empower the diagnosis of additional patients with NFAT1 deficiency, and further defines the detrimental effects associated with long-term use of calcineurin inhibitors.

Identifiants

pubmed: 35789258
pii: S0006-4971(22)00863-1
doi: 10.1182/blood.2022015674
doi:

Substances chimiques

Calcineurin EC 3.1.3.16
NFATC Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1858-1874

Informations de copyright

© 2022 by The American Society of Hematology.

Auteurs

Mehul Sharma (M)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Maggie P Fu (MP)

Department of Medical Genetics, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, BC, Canada.
Genome Science and Technology Program, Faculty of Science, The University of British Columbia, Vancouver, BC, Canada.

Henry Y Lu (HY)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Ashish A Sharma (AA)

Department of Pathology, Emory University, Atlanta, GA.

Bhavi P Modi (BP)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Christina Michalski (C)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Susan Lin (S)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Joshua Dalmann (J)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Areesha Salman (A)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Kate L Del Bel (KL)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Meriam Waqas (M)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Jefferson Terry (J)

Department of Pathology and Laboratory Medicine, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Audi Setiadi (A)

Department of Pathology and Laboratory Medicine, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Pascal M Lavoie (PM)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Wyeth W Wasserman (WW)

Department of Medical Genetics, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, BC, Canada.
Centre for Molecular Medicine and Therapeutics, The University of British Columbia, Vancouver, BC, Canada.

Jill Mwenifumbo (J)

Department of Medical Genetics, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, BC, Canada.

Michael S Kobor (MS)

Department of Medical Genetics, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, BC, Canada.
Genome Science and Technology Program, Faculty of Science, The University of British Columbia, Vancouver, BC, Canada.
Centre for Molecular Medicine and Therapeutics, The University of British Columbia, Vancouver, BC, Canada.

Anna F Lee (AF)

Department of Pathology and Laboratory Medicine, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Florian Kuchenbauer (F)

Terry Fox Laboratory, BC Cancer Agency, The University of British Columbia, Vancouver, BC, Canada.

Anna Lehman (A)

Department of Medical Genetics, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, BC, Canada.

Sylvia Cheng (S)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Anthony Cooper (A)

Department of Orthopaedics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Millan S Patel (MS)

Department of Medical Genetics, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, BC, Canada.

Stuart E Turvey (SE)

Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH